Back to results

Active, not recruitingN/A

A Comparative Effectiveness Study in Heart Transplant Patients of Rejection Surveillance With Cell-free DNA Versus Endomyocardial Biopsy

NCT06414603

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Cedars-Sinai Medical Center

Los Angeles, California, United States

+15 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2024-06-10
Enrollment: 250 participants
Sponsor: Natera, Inc.
Purpose: diagnostic

Locations (16)

Cedars-Sinai Medical CenterLos Angeles, California, United States
University of California, San DiegoSan Diego, California, United States
University of ColoradoAurora, Colorado, United States
Mayo ClinicJacksonville, Florida, United States
AdventHealth OrlandoOrlando, Florida, United States
Kansas University Medical CenterKansas City, Kansas, United States
Brigham and Women's HospitalBoston, Massachusetts, United States
University of MichiganAnn Arbor, Michigan, United States
NYU Langone HealthNew York, New York, United States
Duke UniversityDurham, North Carolina, United States
Thomas Jefferson University HospitalPhiladelphia, Pennsylvania, United States
Medical University of South CarolinaCharleston, South Carolina, United States
University of Texas, Southwestern Medical CenterDallas, Texas, United States
Baylor Scott White - TempleTemple, Texas, United States
University of UtahSalt Lake City, Utah, United States
Inova Schar Heart and Vascular InstituteFalls Church, Virginia, United States

A Comparative Effectiveness Study in Heart Transplant Patients of Rejection Surveillance With Cell-free DNA Versus Endomyocardial Biopsy — TrialFind